Conference Program Home
My Program
All Times EDT
Legend:
CC = Walter E. Washington Convention Center M = Marriott Marquis Washington, DC
* = applied session ! = JSM meeting theme
Activity Details
|
|
|
|
278
|
Tue, 8/9/2022,
10:30 AM -
12:20 PM
|
CC-140A
|
|
Multi-Stage and Seamless Clinical Trials — Contributed Papers
|
|
Biopharmaceutical Section
|
|
Chair(s): Inna Perevozskaya, GSK
|
|
10:35 AM
|
A 2-In-1 Seamless Phase II/III Design with Graphical Approach in Oncology Drug Development
Linda Sun, Merck & Co, Inc.; Heng Zhou, Merck & Co., Inc.; Wen Li, Pfizer, Inc.; Calvin Jia, Merck & Co., Inc.
|
|
10:50 AM
|
A Bayesian Adaptive Two-Stage Design for Rare Disease Clinical Trials
Xiaoqiang Xue, Syneos Health
|
|
11:05 AM
|
Two-Stage Design for Selecting Among Treatments with Two-Dependent Binary Endpoints
Chishu Yin, Syracuse University; Pinyuen Chen, Syracuse University
|
|
11:20 AM
|
Two-Stage Designs with Dual Endpoints
George Zhang, Bristol Myers Squibb; Olivia Tian, Bristol Myers Squibb
|
|
11:35 AM
|
Multi-Stage Transitional Seamless Trial Designs with Different Objectives and Endpoints
Robert Anthony Tumasian III, Columbia University; Bin Cheng, Columbia University; Shein-Chung Chow, Duke University
|
|
11:50 AM
|
Dose Selection Based on Benefit-Risk Score in Seamless Phase 2/3 Adaptive Design
Min Chen, BMS; Ivan Chan, BMS; Shuyu Chu, BMS
|
|
12:05 PM
|
Two-Stage in Restricted Mean Survival Time with Conditional Power in Clinical Studies
Jingyu Huang, Rutgers University ; Yong Lin, Rutgers University; Weichung Joe Shih, Rutgers University; Shou-en Lu, Rutgers University; Kaifeng Lu, Allergan
|
|
